You are here

Catalent

Catalent and Johnson & Johnson Sign Coronavirus Vaccine Manufacturing Deal

Motley Fool

Wed, 04/29/20 - 10:44 pm

drug manufacturing

Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round

Fierce Pharma

Wed, 02/26/20 - 10:24 am

Teva Pharmaceutical

Catalent laying out $315M to snatch another gene therapy CDMO

Fierce Pharma

Mon, 02/3/20 - 10:39 am

Paragon Services

Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win

Motley Fool

Thu, 01/30/20 - 10:53 am

Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More

Yahoo/Zacks.com

Mon, 11/4/19 - 07:33 pm

Jazz Pharmaceuticals

This Company Is Looking to Win Big in Gene Therapy

Motley Fool

Tue, 09/17/19 - 10:58 am

drug manufacturing

Catalent picks up Novavax facilities, 100 employees

Biopharma Dive

Thu, 06/27/19 - 06:27 pm

Paragon Gene Therapy

'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops

Endpoints

Wed, 06/19/19 - 10:29 am

Bristol-Myers Squibb

Scratch that: Biogen's board expansion hits snag as Catalent CEO John Chiminski drops out

Fierce Pharma

Tue, 05/28/19 - 11:50 am

Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon

Xconomy

Mon, 04/15/19 - 10:07 am

Paragon Bioservices

Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services

Endpoints

Tue, 07/3/18 - 10:10 am

Juniper Pharmaceuticals

drug development

With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica

Endpoints

Tue, 09/19/17 - 08:55 am

Catalent Rises on Report Lonza Group Offered to Buy It

Bloomberg

Thu, 04/14/16 - 01:32 pm

China Biotech In Review: Simcere Receives $503 Million Privatization Offer

Seeking Alpha

Sun, 03/17/13 - 11:45 am

Shanghai Pharmaceutical

Pathwork Diagnostics

Sinovac Biotech

Catalent pairs with BASF on biovailability challenges

NJ Biz, NJ

Sat, 04/14/12 - 12:58 pm

Pages